Are there any differences in the regulations of personalized medicine among the USA, EU and Japan?
- PMID: 22978372
- PMCID: PMC3635607
- DOI: 10.1111/j.1365-2125.2012.04462.x
Are there any differences in the regulations of personalized medicine among the USA, EU and Japan?
Comment in
-
Response to the comments from Drs Shimazawa and Ikeda.Br J Clin Pharmacol. 2013 May;75(5):1368-9. doi: 10.1111/j.1365-2125.2012.04461.x. Br J Clin Pharmacol. 2013. PMID: 22978350 Free PMC article. No abstract available.
Comment on
-
Personalized medicine: is it a pharmacogenetic mirage?Br J Clin Pharmacol. 2012 Oct;74(4):698-721. doi: 10.1111/j.1365-2125.2012.04328.x. Br J Clin Pharmacol. 2012. PMID: 22591598 Free PMC article. Review.
References
-
- The Personalized Medicine Coalition. Washington, DC: 2011. The case for personalized medicine. Available at http://www.personalizedmedicinecoalition.org/about/about-personalized-me... (last accessed 17 August 2012)
-
- Yamashiro Y, Shimizu T, Oguchi S, Shioya T, Nagata S, Ohtsuka Y. The estimated incidence of cystic fibrosis in Japan. J Pediatr Gastroenterol Nutr. 1997;24:544–547. - PubMed
-
- Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer. 2002;97:72–81. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources